Asset Details
Do you wish to reserve the book?
Same-day discharge following catheter ablation of atrial fibrillation: a safe and cost-effective approach
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Same-day discharge following catheter ablation of atrial fibrillation: a safe and cost-effective approach
Do you wish to request the book?
Same-day discharge following catheter ablation of atrial fibrillation: a safe and cost-effective approach
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Same-day discharge following catheter ablation of atrial fibrillation: a safe and cost-effective approach
2020
Overview
Introduction: The frequency of catheter ablation for atrial fibrillation (AF) has increased dramatically, stretching resources. Discharge on the same day as treatment may increase the efficiency and throughput. There are limited data regarding the safety of this strategy. Methods: We performed a retrospective analysis of consecutive patients undergoing AF ablation in a tertiary centre and in a district general hospital, and identified those discharged on the same day of treatment. The safety endpoint was any major complication and/or presentation to hospital in the 48-hours post discharge. We performed an economic analysis to calculate potential cost saving. Results: Among a total population of 2628 patients, we identified 727 subjects (61.1±12.5 years, 69.6% male) undergoing day-case AF ablation. Most of them suffered from paroxysmal AF (58%) and underwent a de novo procedure (86.1%). Cryoballoon technique was used in 79.2% of the day-cases, and 91.6% of the procedures were performed under conscious sedation. 1.8% (13) of the participants met the safety composite endpoint, however only 0.7% (5) required at least one day of hospitalisation. Bleeding/haematoma at the femoral access site (0.5%) and pericarditic chest pain (0.5%) were the main reasons for readmission. None experienced cardiac tamponade or other life-threatening complications in the 48-hours post-discharge. Our day-case policy resulted in a cost-saving of approximately £287,422 for our hospital (average of £83,927 annually). Conclusion: In this large multicentre cohort, same-day discharge in selected patients following AF ablation appears to be safe and cost-effective, with a very low rate of early readmission or post-discharge complication.
Publisher
Touch Medical Media Limited
Subject
